Aspiriant, Llc Buys WisdomTree Emerging Markets High Dividend Fund, iShares Core MSCI Emerging Markets, iShares MSCI EAFE Value, Sells Vanguard Total Stock Market, iShares MSCI EAFE, iShares Edge MSCI Min Vol Emerging Markets

• New Purchases: VTEB, WEN, FNDF, AOM, FTSV, ACWX, OEF, SPGI, TFC, VT, GILD, EFG, HDSN,
• Added Positions: DEM, IEMG, EFV, ACWV, VBR, QAI, IUSV, VIG, PG, JNJ, VNQ, VNQI, AGG, IWB, IWN, VEU, SCZ, IWO, BND, MMM, ESTC, IEFA, CSCO, ACWI, IWM, VB, VGSH, RWX, RY, VTV, ABBV, IDV, CRM, CHTR, INTC, MRK, IJR, DVY, CMCSA, V, VBK, AMZN, AMGN, NOK, T, ACN, BSV, SDY, SRE, PRCP, NVS, IBM, NEE, MCD, KMI, D, XOM, GE, QQQ,
• Reduced Positions: IVV, VEA, SPY, VTI, EFA, EEMV, VWO, VCSH, BRK.B, MUB, EEM, IFGL, USB, ALGN, SCHE, CVX, SCHZ, UNP, MSFT, IWV, USMV, RTN, MA, VCIT, SCHM, DHR, PEP, GOOGL, FITB, GOOG, GWX, SCHX, SCHV, LOW, TJX, HON, VYM, SCHW, QCOM, ABT, MDY, SBUX, ENB, PFE, PYPL, NKE, SHV, IWR, IWF, VZ, HYG, VAW, VGT, KO, FB, VV, VUG, WMT, WFC, UNH, SCHD, O, PAYX, IUSG, IJH, RSP, HD, COST, CLX, CINF, BAC, BDX, ADBE,
• Sold Out: SCHH, BBK, SPLV, MPC, EPP, RNP, AEP, SNA, BKNG, FDX, DUK, BA, XLE, DIA, CHCT, HYMB, IVE, TEL, UPS, TD, KMB, CVS, BLK, BK, BMRC, AMT, LBRT,

For the details of ASPIRIANT, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/aspiriant%2C+llc/current-portfolio/portfolio

1. iShares Edge MSCI Min Vol Global (ACWV) - 2,131,526 shares, 16.97% of the total portfolio. Shares added by 6.12%
2. WisdomTree Emerging Markets High Dividend Fund (DEM) - 2,311,507 shares, 7.39% of the total portfolio. Shares added by 766.86%
3. iShares Core MSCI Emerging Markets (IEMG) - 1,702,375 shares, 6.83% of the total portfolio. Shares added by 192.83%
4. iShares National Muni Bond (MUB) - 490,888 shares, 5.50% of the total portfolio. Shares reduced by 2.88%
5. Vanguard Div Appreciation (VIG) - 507,797 shares, 5.20% of the total portfolio. Shares added by 9.84%

Aspiriant, Llc initiated holding in Vanguard Tax-Exempt Bond. The purchase prices were between $45.81 and $55.19, with an estimated average price of $53.67. The stock is now traded at around $52.68. The impact to a portfolio due to this purchase was 0.41%. The holding were 78,455 shares as of .

Aspiriant, Llc initiated holding in The Wendy's Co. The purchase prices were between $7.47 and $23.94, with an estimated average price of $19.79. The stock is now traded at around $18.81. The impact to a portfolio due to this purchase was 0.17%. The holding were 118,319 shares as of .

Aspiriant, Llc initiated holding in Schwab Fundamental International Large Company Ind. The purchase prices were between $18.2 and $29.21, with an estimated average price of $26.02. The stock is now traded at around $21.57. The impact to a portfolio due to this purchase was 0.08%. The holding were 38,302 shares as of .

Aspiriant, Llc initiated holding in iShares Core Moderate Allocation. The purchase prices were between $33.84 and $40.73, with an estimated average price of $38.96. The stock is now traded at around $37.97. The impact to a portfolio due to this purchase was 0.06%. The holding were 16,325 shares as of .

Aspiriant, Llc initiated holding in iShares S&P 100. The purchase prices were between $104.41 and $152.28, with an estimated average price of $138.76. The stock is now traded at around $131.77. The impact to a portfolio due to this purchase was 0.03%. The holding were 2,770 shares as of .

Aspiriant, Llc initiated holding in Vanguard Total World Stock Index. The purchase prices were between $54.48 and $83.17, with an estimated average price of $76. The stock is now traded at around $68.19. The impact to a portfolio due to this purchase was 0.03%. The holding were 4,781 shares as of .

Aspiriant, Llc added to a holding in WisdomTree Emerging Markets High Dividend Fund by 766.86%. The purchase prices were between $29.01 and $46.63, with an estimated average price of $40.47. The stock is now traded at around $34.36. The impact to a portfolio due to this purchase was 6.54%. The holding were 2,311,507 shares as of .

Aspiriant, Llc added to a holding in iShares Core MSCI Emerging Markets by 192.83%. The purchase prices were between $36.22 and $55.44, with an estimated average price of $49.11. The stock is now traded at around $42.86. The impact to a portfolio due to this purchase was 4.5%. The holding were 1,702,375 shares as of .

Aspiriant, Llc added to a holding in iShares MSCI EAFE Value by 171.13%. The purchase prices were between $30.99 and $50.45, with an estimated average price of $44.48. The stock is now traded at around $36.55. The impact to a portfolio due to this purchase was 0.98%. The holding were 438,057 shares as of .

Aspiriant, Llc added to a holding in Vanguard Small-Cap Value by 30.43%. The purchase prices were between $75.8 and $139.04, with an estimated average price of $122.74. The stock is now traded at around $96.60. The impact to a portfolio due to this purchase was 0.9%. The holding were 438,912 shares as of .

Aspiriant, Llc added to a holding in IQ Hedge MultiIQ Hedge Multi-Strategy Tracker by 245.36%. The purchase prices were between $26.67 and $31.05, with an estimated average price of $30.14. The stock is now traded at around $29.27. The impact to a portfolio due to this purchase was 0.7%. The holding were 345,840 shares as of .

Aspiriant, Llc added to a holding in Procter & Gamble Co by 81.77%. The purchase prices were between $97.7 and $127.14, with an estimated average price of $120.29. The stock is now traded at around $116.01. The impact to a portfolio due to this purchase was 0.21%. The holding were 42,477 shares as of .

Aspiriant, Llc sold out a holding in Schwab U.S. REIT. The sale prices were between $27.07 and $48.53, with an estimated average price of $43.11.

Aspiriant, Llc sold out a holding in Marathon Petroleum Corp. The sale prices were between $16.62 and $61.91, with an estimated average price of $46.65.

Aspiriant, Llc sold out a holding in Invesco S&P 500 Low Volatility. The sale prices were between $39.35 and $62.03, with an estimated average price of $56.39.

Aspiriant, Llc sold out a holding in Truist Financial Corp. The sale prices were between $24.4 and $51, with an estimated average price of $43.17.

Aspiriant, Llc sold out a holding in Boeing Co. The sale prices were between $95.01 and $347.45, with an estimated average price of $276.34.

Aspiriant, Llc sold out a holding in Duke Energy Corp. The sale prices were between $64.15 and $102.43, with an estimated average price of $92.02.